Liver cancerGastric cancerColorectal cancerEsophageal cancer
Established
1937
Beds
2,600+
Annual Volume
85,000+
Shanghai
Academician Fan Jia leads China’s flagship liver cancer team; conversion resection rates for advanced HCC at world-class level.
About the Hospital
Zhongshan Hospital of Fudan University is a benchmark among China’s large general hospitals. Its liver cancer surgery (Academician Fan Jia’s team) leads the world, with among the highest annual liver resection volumes globally and mature complex procedures including large-tumor resection and ALPPS.
Cardiology, respiratory medicine and general surgery are all nationally top-ranked, providing hospital-wide support for cancer patients with complex comorbidities; the endoscopy center is among the largest in Asia.
Hospital Strengths
01World-leading liver cancer surgery
Academician Fan Jia’s team established the “Shanghai Fudan criteria” for liver transplantation in HCC; survival outcomes for large-tumor resection lead internationally, with research repeatedly changing international guidelines.
02Hospital-wide comprehensive support
Leading cardiology, respiratory and nephrology departments provide the strongest national support for comorbidity management and perioperative safety.
03Early cancer screening and endoscopy
The GI endoscopy center handles among the highest volumes in Asia, with mature ESD techniques for early GI tumors.
Key Departments
Liver Cancer SurgeryGeneral SurgeryThoracic SurgeryMedical OncologyEndoscopy CenterRadiation Oncology
Coordinated Treatment Directions
01Liver resection, transplantation and conversion therapy
02Minimally invasive colorectal surgery and comprehensive care
03Endoscopic submucosal dissection (ESD) for early GI tumors
04Surgery for cancer patients with cardiovascular disease
Officially Reported Treatment Milestones
One of the world’s largest liver cancer care centers
2012–
Academician Fan Jia’s team performs among the world’s highest volumes of liver resection and transplantation, leading the national primary liver cancer guidelines and promoting conversion therapy.
Radical resection after conversion therapy for advanced liver cancer
2021
Through conversion therapy combining targeted and immune agents, some initially unresectable intermediate-to-advanced patients gained the opportunity for radical resection; the related consensus was led by Zhongshan Hospital.
Accreditations & Platforms
National Clinical Research Center for Radiation & Therapy